Target intelligence / Profile preview

Actin gamma 1 pseudogene 4 (ACTG1P4)

Target: ACTG1P4
Molecular classification: Other (Pseudogene)

Overview

Actin gamma 1 pseudogene 4 (ACTG1P4) is a pseudogene, meaning it is a non-functional segment of DNA that resembles the functional ACTG1 gene but does not code for a functional protein. Pseudogenes generally arise from gene duplication or retrotransposition events and lack the ability to produce functional protein due to mutations or incomplete sequence. Therefore, ACTG1P4 has no established biological function, no known roles in disease, is not a drug target, and is not considered relevant for therapeutic intervention. Its existence mainly provides insight into genome evolution and gene family complexity, but it is not a functional or actionable molecular target[4].

Other names: Actin gamma 1 pseudogene 4

Beyond the preview

Go deeper on Actin gamma 1 pseudogene 4 (ACTG1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin gamma 1 pseudogene 4 (ACTG1P4).

Explore the full profile